Nuvonis Technologies Email Formats

Biotechnology Research • Mariahilfer Straße 101, Vienna, Austria • 1-10 Employees

Nuvonis Technologies Email Formats

Nuvonis Technologies uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@nuvonis.com), used 75% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@nuvonis.com	75%
{first name}.{last name}	john.doe@nuvonis.com	25%

Key Contact at Nuvonis Technologies

Christina Nicolodi

Ceo

Company overview

Headquarters	Mariahilfer Straße 101, Vienna, Vienna 1060, AT
Website	nuvonis.com
NAICS	541714
SIC	283
Keywords	Process Development, Animal Health, Vaccine Development, Influenza, CCX, Vaccine Manufacturing, Cellular Agriculture, Cultured Meat, Animal Vaccine, Newcastle Disease Virus, Avian Cell Banks For Manufacturing, Gmp Master Cell Banks, Gmp Vero Cell Banks, Vector Manufacturing, Vero Cell Banks, Vero Cell Vaccine, Master Cell Bank And Working Cell Bank, Vector Production, Avian Cells, Quail Cells, Focus Forming Assay, Laboratory Meat
Founded	2016
Employees	1-10
Socials

About Nuvonis Technologies

Powering Reliable Vaccine and Vector Production;Welcome to Nuvonis Technologies. Nuvonis Technologies is your trusted partner in biotech, providing high-quality, innovative cell banks for vaccine and vector production. Our experienced team offers in-depth technical support across virus production processes, from vaccine strain improvement to comprehensive analytical services, ensuring a smooth and efficient development journey. GMP Cell Banks You Can Depend On: Nuvonis offers "ready to use" GMP Master and Working Cell Banks produced under serum- and animal-free conditions, guaranteeing quality and safety. Fully characterized, including end-of-production tumorigenicity testing, these cell banks are immediately available for your GMP manufacturing needs. Advancing Vaccine Production with Innovative Avian Cell Lines: Explore the potential of our continuous avian cell line, CCX, derived from primary quail cells. Available in both adherent (CCX.2C4) and suspension (CCX.E10) formats, our Avian Cell Banks provide a reliable and scalable alternative to traditional CEF or egg-based methods. Your Partner in Process Development Excellence: Rely on the Nuvonis team's extensive experience in developing and optimizing vaccine production processes. We offer a proprietary, high-efficiency virus purification process for superior vaccine purity, alongside tailored analytical services, analytical development, and seamless transfer of virus and viral vector assays (e.g., FFA).

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Vice President

Employees by Department

Nuvonis Technologies has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

Nuvonis Technologies has never raised funding before.

Nuvonis Technologies Tech Stack

Discover the technologies and tools that power Nuvonis Technologies's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Astra

WordPress themes

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Elementor

Page builders

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Yoast SEO

SEO

Crocoblock JetElements

WordPress plugins

Frequently asked questions

Nuvonis Technologies is located in Mariahilfer Straße 101, Vienna, AT.

Nuvonis Technologies was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Nuvonis Technologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Nuvonis Technologies

Christina Nicolodi

Ceo

4.8

40,000 users